Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Three Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels: A Double-Blind, Placebo-Controlled Four-Arm Trial

NCT07132801 is registered in ClinicalTrials.gov with Qualia Life Sciences as lead sponsor.

NCT NCT07132801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07132801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Three Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels: A Double-Blind, Placebo-Controlled Four-Arm Trial
Lead sponsor
Qualia Life Sciences
Phase
Not applicable
Overall status
Completed
Start date
April 22, 2026
Completion date
June 5, 2026
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nad, nad+ levels in the blood